COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Scott Weiner appointed to Strategic Advisory Board of Florida Institute for the Commercialization of Public Research
News | 05. 14. 2009
The Florida Institute for the Commercialization of Public Research (The Institute) today announced the formation of its Strategic Advisory Board; 15 distinguished industry experts who will provide counsel on technical challenges associated with raising early stage capital and technology commercialization.
